IndraLab

Statements

YOD1 activates Osteosarcoma. 2 / 2
| 2
reach
"Consistent with previous studies, we showed that overexpression of YOD1 enhanced osteosarcoma progression, including elevated cell proliferation, cell adhesion and inhibited cell apoptosis."
33515913
reach
"Notably, DEX treatment could downregulate YOD1 expression via increasing miR-520a-3p expression, thereby suppressing cell proliferation and cell adhesion, and elevating cell apoptosis in osteosarcoma [MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"
33515913